Lensar (LNSR) Cash from Investing Activities (2019 - 2026)
Lensar (LNSR) reported Cash from Investing Activities of $4.0 million for Q1 2026, up 653.3% year-over-year from $531000.0 in Q1 2025, and down 5.77% quarter-over-quarter from $4.2 million in Q4 2025.
Lensar (LNSR) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash from Investing Activities data on file, last reported at $4.0 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $4.0 million, up 653.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 1276.49% YoY), and the FY2025 annual result was $1.3 million, up 159.42% from the prior year.
- Cash from Investing Activities eased to $4.0 million in Q1 2026 per LNSR's latest filing, from $4.2 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $4.2 million in Q4 2025 and troughed at -$7.5 million in Q2 2025.
- A 5-year average of -$67529.4 and a median of -$10000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities tumbled 45150.0% in 2024, then jumped 653.3% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$57000.0 in 2022, then slumped by 6856.14% to -$4.0 million in 2023, then surged by 150.24% to $2.0 million in 2024, then jumped by 113.1% to $4.2 million in 2025, then slipped by 5.77% to $4.0 million in 2026.
- Business Quant data shows LNSR's Cash from Investing Activities at $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 531,000.00 |
| Mar 31, 2025 | 531,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | -905,000.00 |
| Sep 30, 2024 | -905,000.00 |
| Jun 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Dec 31, 2023 | -3.97 Mn |
| Dec 31, 2023 | -3.97 Mn |